Published: 08-Jul-2020 | Published By: Market Research Store
In the clinical course of COVID-19, researchers from the University of North Carolina School of Medicine and Icahn School of Medicine at Mount Sinai have studied the risk factors that are associated by studying a large number of patients having Inflammatory Bowel Disease (IBD) with the help of an international registry. This forthcoming study is to be published in the journal Gastroenterology.
The time COVID-19 cases were rapidly increasing in the US the researchers came together to form international registry of the people who were suffering from inflammatory bowel disease and COVID-19. SECURE-IBD (Surveillance Epidemiology of Coronavirus under Research Exclusion for Inflammatory Bowel Disease) is the registry and till date has made inclusion from 33 nations of 528 patients.
The co-author of the study Erica Brenner, MD, commented that the purpose of establishing the registry was to help distinguish how COVID-19 affected the patients’ who were having inflammatory bowel disease. The evaluations were made and there were considerations taken about any association between the clinical uniqueness, demographics, and the treatments.
With the help of their study the researchers were able to conclude that corticosteroids, comorbidities, and increasing age are some of factors that are connected with the IBD patients’ suffering from severe conditions of COVID-19. Through this study a casual connection was found but there were no hard core establishments about the fact. In particular, there were no associations found in terms of TNF antagonists and COVID-19.
Ryan Ungaro, MD, gastroenterologist with Mount Sinai Hospital's Feinstein IBD Center, the co-author of the study said that the key findings of the study is that the IBD patients’ should reduce steroid-sparing treatments, which will be quite helpful at this time of the pandemic. No association of TNF antagonist treatment and COVID-19 is a relief as this is the most approved biologic treatment for IBD and increased number of patients have requirement of this therapy.
Market Research Store has published the report on the global inflammatory bowel disease market. The report highlights that the market will gain rapid growth in the coming years owing to the rise in the number of people suffering from inflammatory bowel diseases.
Global White Marble Market Report 2020 - Industry Research Report
Global Yoga Mat Market Report 2020 - Industry Research Report
Global Veterinary Diagnostic Imaging Market Report 2020 - Industry Research Report
Global Pest Control Services Market Report 2020 - Industry Research Report
Global Hydro Processing Catalysts Market Report 2020 - Industry Research ReportView More
Love Hormone Could Help Treat Memory Loss In Alzheimer’s Disease
New research has shown researchers to test the effect of oxytocin on the brain tissue in the labor
Researchers Develop A New Nano Drug To Treat Triple Negative Breast Cancer
The University of Arkansas researchers have created a novel nano drug candidate that possesses the
New Research Shows Seaweed Extract To Be More Effective Than Remdesivir
A new study has shown seaweed extract to be highly effective in treating COVID-19 than remdesivir,
Cannabis Use Is Likely To Prove Evil For The Heart
There are many across globe who love smoking weed. But, according to the American Heart Associatio
A New Blood Test Helps Discover COVID-19 Antibodies Within 20 Minutes
A team of researchers from Monash University has shown the use of blood samples to test the manife